Zobrazeno 1 - 10
of 20
pro vyhledávání: '"S. Patalyak"'
Publikováno v:
EJC Supplements, Vol 13, Iss 1, Pp 2-3 (2015)
Tamoxifen, a selective estrogen receptor modulator, remains a standard of endocrine therapy for estrogen receptor alpha (ERα) positive breast cancer (Goldhirsch et al., 2013). Despite well-known advantages of tamoxifen treatment, approximately one t
Externí odkaz:
https://doaj.org/article/41e9b71012c74971bd13a9abc8303b1b
Publikováno v:
Bûlleten' Sibirskoj Mediciny, Vol 19, Iss 4, Pp 30-37 (2021)
Background. The identification of predictive molecular markers of luminal breast cancer will help to assess the risk of developing distant metastases and determine a personalized approach to predicting the outcome of the disease during hormone therap
Publikováno v:
JOURNAL of SIBERIAN MEDICAL SCIENCES. :62-74
46P ERα heterogeneous expression and the TGF-βRI status in the tumour predicted tamoxifen resistance
Publikováno v:
Annals of Oncology. 32:S18-S19
Publikováno v:
Annals of Oncology. 32:S1353
Publikováno v:
European Journal of Cancer. 138:S41-S42
Autor:
Evgeny Choynzonov, Julia Kzhyshkowska, Elena M. Slonimskaya, S. Patalyak, Tatyana Dronova, Nadejda Cherdyntseva, S. V. Vtorushin, Nataliya Babyshkina
Publikováno v:
Clinical and experimental medicine. 19(4)
The luminal-A-like and luminal-B-like breast cancer groups have distinct biological features that lead to differences in the treatment response and clinical outcome. The aim of this study was to examine the value of the distribution pattern of ERα e
Autor:
M. V. Zavyalova, Nataliya Babyshkina, Evgeny Choynzonov, Elena M. Slonimskaya, Julia Kzhyshkowska, Tatyana Dronova, S. V. Vtorushin, N. Litviakov, S. Patalyak, Nadejda Cherdyntseva
Publikováno v:
Clinical and Experimental Medicine. 17:383-393
Identification of additional biomarkers associated with ER genomic and nongenomic pathways could be very useful to distinguish patients who will benefit from tamoxifen treatment. The aim of this study was to analyze the prognostic significance of the
Publikováno v:
Annals of Oncology. 31:S278
Publikováno v:
AIP Conference Proceedings.
A crosstalk between the estrogen receptor alpha (ERα) and tyrosine kinase receptors contribute to endocrine resistance. We investigated the effect of the four Smad-independent TGF-β signaling components and the distribution pattern of ERα expressi